A Reduced Frequency of GARPFoxp3 T Regulatory Cells in COPD Patients is Associated with Emphysema Phenotype Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD Year: 2021
High Intensity Resistance Training Improves Respiratory, Peripheral, Quality of Life and Emotional Response in Elderly with Parkinson Disease Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Does a Tailored Intervention to Promote Adherence in Patients with Chronic Lung Disease Affect Exacerbations? Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019
Socioeconomic Status and Cleaning: Major Factors Affecting Asthma Control Source: Virtual Congress 2020 – Clinical and functional evaluation of asthmatics Year: 2020
Respiratory Symptoms and Lung Function Depend on Smoking Status and Enviromental Conditions Source: International Congress 2017 – Smoking, apnoea, infection, allergens and other factors Year: 2017
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019
Development of Highly Organized Human Leukocyte Infiltration Patterns and Human Lymphoid Tissue in Lungs of Humanized Immune System (HIS) Mice Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Diffuse Pulmonary Non-Amyloid Light-Chain Deposition Disease: Phenotypes and Outcome Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021
Relation of Respiratory Function and Functional Capacity, Body Composition in Individuals with Alzheimer’s Disease Source: Virtual Congress 2020 – A knowledge update on respiratory muscle function, assessment and training Year: 2020
Understanding of Pharmacokinetics and Exposure Drives use of Nintedanib as a Positive Control Reference Item in a Rat Model of Bleomycin-Induced Fibrosis Source: International Congress 2019 – New mechanistic insights into pulmonary fibrosis Year: 2019
Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case–Control Study of Women Source: Virtual Congress 2020 – Phenotypes of asthma and COPD Year: 2020
The Frequency of Small Airway Dysfunction and Its Relationship with Disease Control in Chronic Airway Diseases Source: Virtual Congress 2021 – Lung function testing in the management of obstructive diseases Year: 2021
Co-expression Networks Analysis in Patients with Asthma and Healthy Controls Challenged with Rhinovirus Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019
Comparison of Exercise Capacity Respiratory Muscle Strength and Depression in Non-Small Cell Lung Cancer Patients and Healthy Controls Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019
Physical Training Improves Lung Function and Mechanics and Pulmonary and Systemic Immune Response in Eutrophic Women Source: Virtual Congress 2020 – Novel insights into exercise training Year: 2020
Impact of Eosinophilia and Time on Lung Function Decline in Adult Asthma Source: International Congress 2018 – Clinical determinants and biomarkers of COPD Year: 2018
Respiratory and Motor Phenotypes and Correlations with Diaphragm Function in Patients with Late-Onset Pompe Disease (LOPD) Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions Year: 2018
A First-in-Class PRS Inhibitor, DWN12088, as a Novel Therapeutic Agent for Systemic Sclerosis and Associated Interstitial Lung Disease Source: Virtual Congress 2021 – Exploring the phenotypic heterogeneity across rare diffuse parenchymal lung diseases Year: 2021
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade in Lung Cancer – A restrospective study. Source: International Congress 2019 – Treatment of lung cancer Year: 2019